DecisionView, a leading provider of web software solutions, has released StudyOptimizer 4.4 to help clinical trial organizations plan, forecast and track patient enrollment.

The new version of StudyOptimizer focuses on cost modeling and visibility to enable pharmaceutical companies to easily optimize the time and cost tradeoffs for their clinical trial enrollment plans. In addition, when studies go off track, the new features allow users to model and estimate the cost of different rescue scenarios.

"In planning clinical trials, patient recruitment and enrollment is a major potential source of delays," said Alan Louie, research director at IDC Health Insights. "With as much as 50% of trial project plans requiring rescue and rework, the cost of inefficiency can be high."

DecisionView said StudyOptimizer 4.4 aims to help optimize clinical trials and bring down drug development costs.